Fund Holdings — Cutter Capital Management, LP

Total Portfolio Value
$328.13M
Total Bought
$182.91M
Total Sold
$120.96M
Net Transaction
+$61.95M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
MERCK & CO INC(MRK)0175,600+175,600021,7396.63%+21,739
AMGEN INC(AMGN)064,201+64,201020,0606.11%+20,060
KENVUE INC(KVUE)0960,400+960,400017,4605.32%+17,460
ULTRAGENYX PHARMACEUTICAL IN(RARE)0365,000+365,000015,0024.57%+15,002
CYTOKINETICS INC(CYTK)0236,900+236,900012,8353.91%+12,835
LEGEND BIOTECH CORP(LEGN)79,830343,130+263,3004,47815,1974.63%+10,720
INSMED INC(INSM)227,337227,637+3006,16815,2524.65%+9,084
HARMONY BIOSCIENCES HLDGS IN(HRMY)0295,771+295,77108,9232.72%+8,923
AVANTOR INC(AVTR)0400,000+400,00008,4802.58%+8,480
VERA THERAPEUTICS INC(VERA)0230,000+230,00008,3212.54%+8,321
BRIDGEBIO PHARMA INC(BBIO)0311,700+311,70007,8952.41%+7,895
BIOMARIN PHARMACEUTICAL INC(BMRN)175,000273,533+98,53315,28522,5206.86%+7,235
BIOGEN INC(BIIB)52,00076,726+24,72611,21317,7875.42%+6,574
ROYALTY PHARMA PLC(RPRX)411,540692,300+280,76012,49818,2565.56%+5,757
ENLIVEN THERAPEUTICS INC0222,985+222,98505,2111.59%+5,211
PFIZER INC(PFE)0185,200+185,20005,1821.58%+5,182
EVOLUS INC(EOLS)0465,300+465,30005,0491.54%+5,049
ARCELLX INC
COMMON STOCK
107,000187,000+80,0007,44210,3213.15%+2,879
CRISPR THERAPEUTICS AG(CRSP)120,185201,497+81,3128,19210,8833.32%+2,691
SAREPTA THERAPEUTICS INC(SRPT)94,37989,379-5,00012,21814,1224.30%+1,904
BIOCRYST PHARMACEUTICALS INC(BCRX)2,105,4591,975,298-130,16110,69612,2073.72%+1,512
AVADEL PHARMACEUTICALS PLC541,926733,001+191,0759,15310,3063.14%+1,153
GILEAD SCIENCES INC(GILD)265,436292,959+27,52319,44320,1006.13%+657
TEVA PHARMACEUTICAL INDS LTD(TEVA)1,135,710911,900-223,81016,02514,8184.52%-1,206
CABALETTA BIO INC(CABA)157,9640-157,9642,6950—-2,695
PLIANT THERAPEUTICS INC(PLRX)194,1190-194,1192,8920—-2,892
KYVERNA THERAPEUTICS INC(KYTX)166,5140-166,5144,1360—-4,136
VIRIDIAN THERAPEUTICS INC(VRDN)278,6380-278,6384,8790—-4,879
IONIS PHARMACEUTICALS INC(IONS)289,366160,166-129,20012,5447,6342.33%-4,911
PERRIGO CO PLC(PRGO)322,114100,000-222,11410,3692,5680.78%-7,801
AGIOS PHARMACEUTICALS INC(AGIO)288,5800-288,5808,4380—-8,438
ELI LILLY & CO(LLY)11,0400-11,0408,5890—-8,589
EXELIXIS INC(EXEL)398,7620-398,7629,4630—-9,463
HALOZYME THERAPEUTICS INC(HALO)255,0490-255,04910,3750—-10,375
ACADIA PHARMACEUTICALS INC658,4090-658,40912,1740—-12,174
REGENERON PHARMACEUTICALS(REGN)16,3600-16,36015,7460—-15,746
BRISTOL-MYERS SQUIBB CO(BMY)446,9000-446,90024,2350—-24,235
Page 1 of 1
Cutter Capital Management, LP — 13F Holdings — Q2 2024 | TickerTrail